CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions
Clinical Transplantation · 2024
DOI: 10.1111/ctr.15324 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Ilaria Gandolfini und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Surgery, University of Parma, Parma, Italy. Hauptthemen laut MEDLINE: Chemokine CXCL10, Biomarkers, Kidney Transplantation, Chemokine CXCL9. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Surgery, University of Parma, Parma, Italy.
- Nephrology Unit, University Hospital of Parma, Parma, Italy.
- Translational Transplant Research Center and Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Sara Alibrandi, Paolo Cravedi
Zitieren
APA
Gandolfini, I., Mordà, B., Martinelli, E., Delsante, M., Rossi, G., Gentile, M., Alibrandi, S., Salvetti, D., Fiaccadori, E., Palmisano, A., Cravedi, P., & Maggiore, U. (2024). CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions. Clinical Transplantation. https://doi.org/10.1111/ctr.15324
Vancouver
Gandolfini I, Mordà B, Martinelli E, Delsante M, Rossi G, Gentile M, et al. CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions. Clinical Transplantation. 2024. doi:10.1111/ctr.15324
BibTeX
@article{Gandolfini2024,
author = {Gandolfini, Ilaria and Mordà, Benedetta and Martinelli, Elene and Delsante, Marco and Rossi, GiovanniMaria and Gentile, Micaela and Alibrandi, Sara and Salvetti, Daniel and Fiaccadori, Enrico and Palmisano, Alessandra and Cravedi, Paolo and Maggiore, Umberto},
title = {CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions},
journal = {Clinical Transplantation},
year = {2024},
doi = {10.1111/ctr.15324}
}
EUVIMED